Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Agencies Call Attention To Link Between Black Cohosh, Liver Risks

This article was originally published in The Tan Sheet

Executive Summary

The UK's Medicines & Healthcare products Regulatory Agency (MHRA) will add warnings to black cohosh products about the risk of liver disorders associated with use of the herbal, the agency states in a release July 18

You may also be interested in...



Black Cohosh Case Report Used By Foreign Health Bodies Cast Into Doubt

Expert testimony during a black cohosh lawsuit exposed the omission of relevant data in a published case report alleging a causal relationship between the botanical and liver damage. A U.S. District Court dismissed the suit Sept. 8 due to the plaintiffs' inability to establish causation

Black Cohosh Case Report Used By Foreign Health Bodies Cast Into Doubt

Expert testimony during a black cohosh lawsuit exposed the omission of relevant data in a published case report alleging a causal relationship between the botanical and liver damage. A U.S. District Court dismissed the suit Sept. 8 due to the plaintiffs' inability to establish causation

Black Cohosh Case Report Used By Foreign Health Bodies Cast Into Doubt

Expert testimony during a black cohosh lawsuit exposed the omission of relevant data in a published case report alleging a causal relationship between the botanical and liver damage. A U.S. District Court dismissed the suit Sept. 8 due to the plaintiffs' inability to establish causation

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel